Skip to main content

Peer Review reports

From: Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)

Original Submission
31 May 2011 Submitted Original manuscript
27 Jun 2011 Author responded Author comments - Pierre-Alain Clavien
Resubmission - Version 2
27 Jun 2011 Submitted Manuscript version 2
23 Jul 2011 Author responded Author comments - Pierre-Alain Clavien
Resubmission - Version 3
23 Jul 2011 Submitted Manuscript version 3
Publishing
10 Aug 2011 Editorially accepted
10 Aug 2011 Article published 10.1186/1471-2407-11-346

You can find further information about peer review here.

Back to article page